Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults
The Centers for Disease Control and Prevention convened panels of anthrax experts to review and update guidelines for anthrax postexposure prophylaxis and treatment. The panels included civilian and military anthrax experts and clinicians with experience treating anthrax patients. Specialties repres...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2014-02-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/20/2/13-0687_article |
| _version_ | 1811228017121296384 |
|---|---|
| author | Katherine A. Hendricks Mary E. Wright Sean V. Shadomy John S. Bradley Meredith G. Morrow Andy T. Pavia Ethan Rubinstein Jon-Erik C. Holty Nancy E. Messonnier Theresa L. Smith Nicki Pesik Tracee A. Treadwell William A. Bower |
| author_facet | Katherine A. Hendricks Mary E. Wright Sean V. Shadomy John S. Bradley Meredith G. Morrow Andy T. Pavia Ethan Rubinstein Jon-Erik C. Holty Nancy E. Messonnier Theresa L. Smith Nicki Pesik Tracee A. Treadwell William A. Bower |
| author_sort | Katherine A. Hendricks |
| collection | DOAJ |
| description | The Centers for Disease Control and Prevention convened panels of anthrax experts to review and update guidelines for anthrax postexposure prophylaxis and treatment. The panels included civilian and military anthrax experts and clinicians with experience treating anthrax patients. Specialties represented included internal medicine, pediatrics, obstetrics, infectious disease, emergency medicine, critical care, pulmonology, hematology, and nephrology. Panelists discussed recent patients with systemic anthrax; reviews of published, unpublished, and proprietary data regarding antimicrobial drugs and anthrax antitoxins; and critical care measures of potential benefit to patients with anthrax. This article updates antimicrobial postexposure prophylaxis and antimicrobial and antitoxin treatment options and describes potentially beneficial critical care measures for persons with anthrax, including clinical procedures for infected nonpregnant adults. Changes from previous guidelines include an expanded discussion of critical care and clinical procedures and additional antimicrobial choices, including preferred antimicrobial drug treatment for possible anthrax meningitis. |
| first_indexed | 2024-04-12T09:51:25Z |
| format | Article |
| id | doaj.art-d44961cd14994dd9837676ad1db4fb90 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-04-12T09:51:25Z |
| publishDate | 2014-02-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-d44961cd14994dd9837676ad1db4fb902022-12-22T03:37:49ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592014-02-0120210.3201/eid2002.130687Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in AdultsKatherine A. HendricksMary E. WrightSean V. ShadomyJohn S. BradleyMeredith G. MorrowAndy T. PaviaEthan RubinsteinJon-Erik C. HoltyNancy E. MessonnierTheresa L. SmithNicki PesikTracee A. TreadwellWilliam A. BowerThe Centers for Disease Control and Prevention convened panels of anthrax experts to review and update guidelines for anthrax postexposure prophylaxis and treatment. The panels included civilian and military anthrax experts and clinicians with experience treating anthrax patients. Specialties represented included internal medicine, pediatrics, obstetrics, infectious disease, emergency medicine, critical care, pulmonology, hematology, and nephrology. Panelists discussed recent patients with systemic anthrax; reviews of published, unpublished, and proprietary data regarding antimicrobial drugs and anthrax antitoxins; and critical care measures of potential benefit to patients with anthrax. This article updates antimicrobial postexposure prophylaxis and antimicrobial and antitoxin treatment options and describes potentially beneficial critical care measures for persons with anthrax, including clinical procedures for infected nonpregnant adults. Changes from previous guidelines include an expanded discussion of critical care and clinical procedures and additional antimicrobial choices, including preferred antimicrobial drug treatment for possible anthrax meningitis.https://wwwnc.cdc.gov/eid/article/20/2/13-0687_articleanthraxBacillus anthracisbacteriabioterrorism and preparednessantitoxinraxibacumab |
| spellingShingle | Katherine A. Hendricks Mary E. Wright Sean V. Shadomy John S. Bradley Meredith G. Morrow Andy T. Pavia Ethan Rubinstein Jon-Erik C. Holty Nancy E. Messonnier Theresa L. Smith Nicki Pesik Tracee A. Treadwell William A. Bower Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults Emerging Infectious Diseases anthrax Bacillus anthracis bacteria bioterrorism and preparedness antitoxin raxibacumab |
| title | Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults |
| title_full | Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults |
| title_fullStr | Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults |
| title_full_unstemmed | Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults |
| title_short | Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults |
| title_sort | centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults |
| topic | anthrax Bacillus anthracis bacteria bioterrorism and preparedness antitoxin raxibacumab |
| url | https://wwwnc.cdc.gov/eid/article/20/2/13-0687_article |
| work_keys_str_mv | AT katherineahendricks centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT maryewright centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT seanvshadomy centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT johnsbradley centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT meredithgmorrow centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT andytpavia centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT ethanrubinstein centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT jonerikcholty centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT nancyemessonnier centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT theresalsmith centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT nickipesik centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT traceeatreadwell centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults AT williamabower centersfordiseasecontrolandpreventionexpertpanelmeetingsonpreventionandtreatmentofanthraxinadults |